Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00055809
Status:
COMPLETED
Last Update Posted:
2013-01-23
First Post:
2003-03-06
Brief Title:
Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Regional Gastrointestinal Carcinoid Tumor |
| Metastatic Gastrointestinal Carcinoid Tumor |
| Recurrent Gastrointestinal Carcinoid Tumor |
Keywords: